Synthesis and evaluation of platinum complexes with potential antitumor activity
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/131423 |
Resumo: | A novel series of platinum (II) complexes was synthesized and the complexes were evaluated for their in vitro cytotoxicity against four human cancer cells lines. Five platinum complexes showed activity against at least one tumor cell line. Complexes 3 and 6 were promising, being active, at micromolar concentrations, against all the assayed tumor cell lines. Compound 3 was selected for further studies in mice with Ehrlich solid tumors and it was able to reduce the rate of tumor growth significantly during the first seven days. However, at the end of the experiments, there was no significant difference between the group of animals treated with 3 and the control group. The low solubility of the compound in the assay conditions can explain, at least in part, these results. |
id |
USP-31_f2c4224e5912870c20ac1e4c3d1124d4 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/131423 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Synthesis and evaluation of platinum complexes with potential antitumor activity/Cytotoxic activityPlatinum complexes/ Ehrlich solid tumor activity.A novel series of platinum (II) complexes was synthesized and the complexes were evaluated for their in vitro cytotoxicity against four human cancer cells lines. Five platinum complexes showed activity against at least one tumor cell line. Complexes 3 and 6 were promising, being active, at micromolar concentrations, against all the assayed tumor cell lines. Compound 3 was selected for further studies in mice with Ehrlich solid tumors and it was able to reduce the rate of tumor growth significantly during the first seven days. However, at the end of the experiments, there was no significant difference between the group of animals treated with 3 and the control group. The low solubility of the compound in the assay conditions can explain, at least in part, these results.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2017-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/13142310.1590/s2175-97902017000115235Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 1 (2017); e15235-Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 1 (2017); e15235-Brazilian Journal of Pharmaceutical Sciences; Vol. 53 No. 1 (2017); e15235-2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/131423/127803Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessFreire, Rachel Lima MarcelinoMarques, Maria Betânia de FreitasSouza-Fagundes, Elaine Maria deOliveira, Renata Barbosa deAlves, Ricardo José2017-04-20T20:28:50Zoai:revistas.usp.br:article/131423Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2017-04-20T20:28:50Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Synthesis and evaluation of platinum complexes with potential antitumor activity |
title |
Synthesis and evaluation of platinum complexes with potential antitumor activity |
spellingShingle |
Synthesis and evaluation of platinum complexes with potential antitumor activity Freire, Rachel Lima Marcelino /Cytotoxic activity Platinum complexes/ Ehrlich solid tumor activity. |
title_short |
Synthesis and evaluation of platinum complexes with potential antitumor activity |
title_full |
Synthesis and evaluation of platinum complexes with potential antitumor activity |
title_fullStr |
Synthesis and evaluation of platinum complexes with potential antitumor activity |
title_full_unstemmed |
Synthesis and evaluation of platinum complexes with potential antitumor activity |
title_sort |
Synthesis and evaluation of platinum complexes with potential antitumor activity |
author |
Freire, Rachel Lima Marcelino |
author_facet |
Freire, Rachel Lima Marcelino Marques, Maria Betânia de Freitas Souza-Fagundes, Elaine Maria de Oliveira, Renata Barbosa de Alves, Ricardo José |
author_role |
author |
author2 |
Marques, Maria Betânia de Freitas Souza-Fagundes, Elaine Maria de Oliveira, Renata Barbosa de Alves, Ricardo José |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Freire, Rachel Lima Marcelino Marques, Maria Betânia de Freitas Souza-Fagundes, Elaine Maria de Oliveira, Renata Barbosa de Alves, Ricardo José |
dc.subject.por.fl_str_mv |
/Cytotoxic activity Platinum complexes/ Ehrlich solid tumor activity. |
topic |
/Cytotoxic activity Platinum complexes/ Ehrlich solid tumor activity. |
description |
A novel series of platinum (II) complexes was synthesized and the complexes were evaluated for their in vitro cytotoxicity against four human cancer cells lines. Five platinum complexes showed activity against at least one tumor cell line. Complexes 3 and 6 were promising, being active, at micromolar concentrations, against all the assayed tumor cell lines. Compound 3 was selected for further studies in mice with Ehrlich solid tumors and it was able to reduce the rate of tumor growth significantly during the first seven days. However, at the end of the experiments, there was no significant difference between the group of animals treated with 3 and the control group. The low solubility of the compound in the assay conditions can explain, at least in part, these results. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/131423 10.1590/s2175-97902017000115235 |
url |
https://www.revistas.usp.br/bjps/article/view/131423 |
identifier_str_mv |
10.1590/s2175-97902017000115235 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/131423/127803 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 1 (2017); e15235- Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 1 (2017); e15235- Brazilian Journal of Pharmaceutical Sciences; Vol. 53 No. 1 (2017); e15235- 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222912913866752 |